The nasogastric tube market was valued for $401.95 million in 2023 and is estimated to reach $693.09 million by 2035, exhibiting a CAGR of 4.6% from 2024 to 2035. Nasogastric tubes (NG tubes) are essential medical devices used to deliver nutrients, medications, and fluids directly into the stomach or remove gastric contents for diagnostic or therapeutic purposes. These flexible, hollow tubes are inserted through the nasal passage into the stomach and are indispensable in managing patients with cancer, gastrointestinal disorders, or requiring gastric decompression.
The nasogastric tube market growth is driven by surge in demand for rise in incidence of chronic diseases such as cancer, neurological disorders, and gastrointestinal disorders and technological advancements in nasogastric tubes. These conditions frequently necessitate enteral feeding due to complications that prevent adequate oral intake. For instance, according to the U.S. Department of Health & Human Services every 40 seconds, someone in the U.S. has a stroke and every year, more than 795,000 people in the U.S. have a stroke which is a leading cause of serious long-term disability. Thus, such conditions increase the adoption of nasogastric tubes.
Further, for instance, patients undergoing chemotherapy or radiation therapy for cancer often experience severe nausea and mucositis, making oral feeding challenging. Similarly, individuals with diabetes may suffer from gastroparesis, a condition that delays stomach emptying, requiring alternative nutritional support methods. Thus, growth in prevalence of chronic diseases directly correlates with increased demand for nasogastric tubes.
Furthermore, the market is additionally supported by the growing number of elderly people worldwide, who are more likely to experience chronic illnesses and eating challenges. Adoption has also been encouraged by developments in tube materials, such as silicone and polyurethane, which enhance patient comfort and lessen discomfort. Because NG tubes are minimally intrusive, hospitals and home healthcare services have been using them more and more, which has led to market expansion.
Moreover, an important contributing aspect has also been the increased emphasis on nutritional support in critical care environments. NG tubes offer a dependable and effective way to precisely enteral feed patients recovering from surgeries or suffering from serious illnesses. Additionally, tubes with anti-clogging designs and radiopaque markings for precise positioning have been developed, improving their safety and effectiveness and leading to broader acceptance. Another significant driver is the increasing utilization of NG tubes in pediatrics and neonatal care. Premature and critically ill infants often depend on these devices for feeding and medication administration. This segment’s growth is fueled by improvements in neonatal care facilities and a better understanding of infant nutrition.
Further, nasogastric tubes have shortcomings, including the potential for esophageal and nasal irritation, patient discomfort, and problems such aspiration pneumonia from improper implantation. Their use may be restricted by these problems, especially for long-term applications. In addition, the requirement for qualified medical personnel to guarantee correct insertion and upkeep raises operating expenses, which could be an obstacle in environments with limited resources.
The nasogastric tube market holds significant potential with the rising adoption of home healthcare services, particularly in developed regions. The shift towards portable and user-friendly NG tubes, combined with telemedicine integration for remote monitoring, presents an opportunity to expand access and convenience. Emerging markets in Asia-Pacific and Latin America, with growing healthcare infrastructure and awareness, also offer untapped potential for manufacturers.
The nasogastric tube market is segmented into type, application, end user, and region. By type, it is further categorized into levin tube, Salem sump tube, and others. By application, the market is fragmented into neurological disorders, cancer, and others. By end user, the market is segregated into hospitals, home care, and others.Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global nasogastric tube market are Becton, Dickinson and Company, QMD (Qure Medical Devices), Angiplast Pvt. Ltd., Securmed, Vygon, Cardinal Health, Poly Medicure Limited, Guangdong Baihe Medical Technology Co., Ltd., Sterimed Group, and Avanos Medical, Inc.
The nasogastric tube market growth is driven by surge in demand for rise in incidence of chronic diseases such as cancer, neurological disorders, and gastrointestinal disorders and technological advancements in nasogastric tubes. These conditions frequently necessitate enteral feeding due to complications that prevent adequate oral intake. For instance, according to the U.S. Department of Health & Human Services every 40 seconds, someone in the U.S. has a stroke and every year, more than 795,000 people in the U.S. have a stroke which is a leading cause of serious long-term disability. Thus, such conditions increase the adoption of nasogastric tubes.
Further, for instance, patients undergoing chemotherapy or radiation therapy for cancer often experience severe nausea and mucositis, making oral feeding challenging. Similarly, individuals with diabetes may suffer from gastroparesis, a condition that delays stomach emptying, requiring alternative nutritional support methods. Thus, growth in prevalence of chronic diseases directly correlates with increased demand for nasogastric tubes.
Furthermore, the market is additionally supported by the growing number of elderly people worldwide, who are more likely to experience chronic illnesses and eating challenges. Adoption has also been encouraged by developments in tube materials, such as silicone and polyurethane, which enhance patient comfort and lessen discomfort. Because NG tubes are minimally intrusive, hospitals and home healthcare services have been using them more and more, which has led to market expansion.
Moreover, an important contributing aspect has also been the increased emphasis on nutritional support in critical care environments. NG tubes offer a dependable and effective way to precisely enteral feed patients recovering from surgeries or suffering from serious illnesses. Additionally, tubes with anti-clogging designs and radiopaque markings for precise positioning have been developed, improving their safety and effectiveness and leading to broader acceptance. Another significant driver is the increasing utilization of NG tubes in pediatrics and neonatal care. Premature and critically ill infants often depend on these devices for feeding and medication administration. This segment’s growth is fueled by improvements in neonatal care facilities and a better understanding of infant nutrition.
Further, nasogastric tubes have shortcomings, including the potential for esophageal and nasal irritation, patient discomfort, and problems such aspiration pneumonia from improper implantation. Their use may be restricted by these problems, especially for long-term applications. In addition, the requirement for qualified medical personnel to guarantee correct insertion and upkeep raises operating expenses, which could be an obstacle in environments with limited resources.
The nasogastric tube market holds significant potential with the rising adoption of home healthcare services, particularly in developed regions. The shift towards portable and user-friendly NG tubes, combined with telemedicine integration for remote monitoring, presents an opportunity to expand access and convenience. Emerging markets in Asia-Pacific and Latin America, with growing healthcare infrastructure and awareness, also offer untapped potential for manufacturers.
The nasogastric tube market is segmented into type, application, end user, and region. By type, it is further categorized into levin tube, Salem sump tube, and others. By application, the market is fragmented into neurological disorders, cancer, and others. By end user, the market is segregated into hospitals, home care, and others.Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global nasogastric tube market are Becton, Dickinson and Company, QMD (Qure Medical Devices), Angiplast Pvt. Ltd., Securmed, Vygon, Cardinal Health, Poly Medicure Limited, Guangdong Baihe Medical Technology Co., Ltd., Sterimed Group, and Avanos Medical, Inc.
Key benefits of the Study
- The study provides an in-depth analysis of the market with current and future trends to elucidate the imminent investment pockets.
- Information regarding key drivers, restraints, and opportunities along with their impact analysis on the market is provided in the report.
- Porter's five forces analysis illustrates the potency of buyers and suppliers operating in the industry.
- The quantitative analysis of the Nasogastric Tube Market from 2023 to 2035 is provided to determine the market potential.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Patient/epidemiology data at country, region, global level
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- SWOT Analysis
Key Market Segments
By Type
- Levin Tube
- Salem Sump Tube
- Others
By Application
- Neurological Disorders
- Cancer
- Others
By End User
- Hospitals
- Home Care
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa,
- Saudi Arabia
- Rest of LAMEA
Key Market Players
- Angiplast Pvt. Ltd.
- Vygon
- Sterimed Group
- Avanos Medical, Inc.
- QMD
- Becton, Dickinson and Company
- Poly Medicure Limited
- Cardinal Health
- Securmed
- Guangdong Baihe Medical Technology Co., Ltd.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: NASOGASTRIC TUBE MARKET, BY TYPE
CHAPTER 5: NASOGASTRIC TUBE MARKET, BY APPLICATION
CHAPTER 6: NASOGASTRIC TUBE MARKET, BY END USER
CHAPTER 7: NASOGASTRIC TUBE MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Companies Mentioned
- Angiplast Pvt. Ltd.
- Vygon
- Sterimed Group
- Avanos Medical, Inc.
- QMD
- Becton, Dickinson and Company
- Poly Medicure Limited
- Cardinal Health
- Securmed
- Guangdong Baihe Medical Technology Co., Ltd.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
